DISRUPTIONS OF ELASTIC ARTERIES PROPERTIES AND ENDOTHELIAL FUNCTION: MODERN METHODS FOR CORRECTION AND PREVENTION
https://doi.org/10.15829/1728-8800-2015-3-75-81
- Р Р‡.МессенРТвЂВВВВВВВВжер
- РћРТвЂВВВВВВВВнокласснРСвЂВВВВВВВВРєРСвЂВВВВВВВВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВВВВВВВВровать ссылку
Full Text:
Abstract
Disorders of arterial elastic properties and endothelial dysfunction are important cardiovascular risk factors and early markers of arterial damage. The review focuses on the results of randomized trials of risk factors influence on taut-elastic arterial properties, modern approaches to the correction and prevention that include life style modification and pharmacological media that are available in broad medical practice. The directions are discussed of the application of novel classes of drugs and potential treatment strategies for the correction of arterial stiffness and endothelial dysfunction.
About the Author
A. F. Kolpakova
FSBI Construction-Technological Institute of Information Technics SD RAS. Novosibirsk, Russia
Russian Federation
Russian Federation
References
1. Katz YaA, Parkhonyuk EV, Akimova NS. Stiffness of vascular wall from the position of damage to connective tissue with the cardiovascular diseases. Fundamental research 2013; 5:189-94. Russian (Kats Ya. A., Parkhonyuk E. V., Akimova N. S. Zhestkost' sosudistoi stenki s pozitsii povrezhdeniya soedinitel'noi tkani pri serdech¬no-sosudistykh zabolevaniyakh. Fundamental'nye issledovaniya 2013; 5:189-94). 21.
2. Cardiovascular prevention. National recommendations. Cardiovascular Therapy and Prevention 2011; 10(6): 1-64. Russian (Kardiovaskulyarnaya profilaktika. Natsional'nye rekomendatsii. Kardiovaskulyarnaya terapiya i profilaktika 22. 2011; 10(6):1-64).
3. Lukyanov MM, Boytsov SA. Stiffness of arterial wall as the factor of cardiovascular risk and forecast in the clinical practice. Heart 2010; 9, 3(53): 156-9. Russian 23. (Luk'yanov M. M., Boitsov S. A. Zhestkost' arterial'noi stenki kak faktor serdechno-sosudistogo riska i prognoza v klinicheskoi praktike. Serdtse 2010; 9, 3(53): 156-9).
4. Popkova TV, Novikov DS, Nasonov EL. Cardiovascular factors of risk with the rheumatic diseases: connection with the inflammation. Diseases of heart and vessels 2010; 2: 46-53. Russian (Popkova T.V., Novikova D.S., Nasonov E. L. Kardiovaskulyarnye faktory riska pri revmaticheskikh zabolevaniyakh: svyaz' s vospaleniem. Bolezni serdtsa i sosudov 2010; 2: 46-53). .
5. Shilkina NP, Savina Zh.E, Yunonin IE, et al. Stiffness constants of vascular wall in patients with system lupus erythematosis and hypertonic disease. Clinical pharmacology and the therapy 2012; 21(3): 54-7. Russian (Shilkina N. P., Savina Zh. E., Yunonin I. E. i dr. Parametry zhestkosti sosudistoi stenki u patsientov s sistemnoi krasnoi volchankoi i gipertonicheskoi bolezn'yu. Klinicheskaya farmakologiya i terapiya 2012; 21(3): 54-7).
6. Koryakina LB, Pivovarov YuI, Kurilskaya TE, et al. Dysfunction of vascular endothelium at arterial hypertension and coronary disease (literature review). Bulletin VSNC SB RAMS 2013; 2 (90) Part 1: 160-70. Russian (Koryakina L. B., Pivovarov Yu. I., Kuril'skaya T. E. i dr. Disfunktsiya sosudistogo endoteliya pri arterial'noi gipertonii i ishemicheskoi bolezni serdtsa (obzor literatury). Byulleten' VSNTs SO RAMN 2013; 2(90) Chast' 1: 160-70).
7. Broyaka NA, Senchikhin VN, Lyamina SV. Arterial rigidity - reliable marker of endothelial dysfunction in initial development stages of arterial hypertension. Arterial hypertension 2008; 14 (4): 336-40. Russian (Broyaka N. A., Senchikhin V. N., Lyamina S. V. Arterial'naya rigidnost' - nadezhnyi marker endotelial'noi disfunktsii na nachal'nykh etapakh razvitiya arterial'noi gipertonii. Arterial'naya gipertenziya 2008; 14(4): 336-40).
8. Van Bortel LM, Laurent S, Boutouyrie P, et al. Artery Society; European Society of Hypertension Working Group on Vascular Structure and Function; European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens 2012; 30: 445-8.
9. Jani B, Rajkumar C. Ageing and vascular ageing. Postgrad Med J 2006; 82: 357-62.
10. Nilsson PM. Hemodynamic Aging as the consequence of structural changes associated with early vascular aging (EVA). Aging Dis 2014; 5(2): 109-13.
11. Sinkevich DA, Protasov KV, Dzizinskiy AA. Concept of "vascular age" as new approach to the estimation of the vascular risk. Siberian medical Journal 2011; 6: 9-13. Russian (Sinkevich D. A., Protasov K. V., Dzizinskii A. A. Kontseptsiya "sosudistogo vozrasta" kak novyi podkhod k otsenke sosudistogo riska. Sibirskii meditsinskii zhurnal 2011; 6: 9-13)
12. Huynh QL, Blizzard CL, Sharman JE, et al. The cross-sectional association of sitting time with carotid artery stiffness in young adults. BMJ Open 2014. https://doi.org/10.1136/ bmjopen-2013-004384.
13. Yu-Jie W, Hui-Liang L, Bing L, et al. Impact of smoking and smoking cessation on arterial stiffness in healthy participants. Angiology 2013; 64 (4): 273-80.
14. Almeida IM, Barreira JC, Oliveira MB, et al. Dietary antioxidant supplements: benefits of their combined use. Food Chem. Toxicol 2011; 49: 3232-7.
15. Poznyakovskiy VM, Guryanov Yu.G, Bebenin BB. Food and biologically active additives: characteristic, application, control. 3rd publ., corr. and suppl. Kemerovo: Kuzbassvuz izdatel'stvo 2011; 275 p. Russian (Poznyakovskii V. M., Gur'yanov Yu. G., Bebenin V. V. Pishchevye i biologicheski aktivnye dobavki: kharakteristika, primenenie, kontrol'. 3-e izd., ispr. i dop. Kemerovo: Kuzbassvuz izdat. 2011; 18. 275 s).
16. Martlnez-Augustin O, Aguilera CM, Gil-Campos M, et al. Bioactive anti-obesity food components. Int J Vitam Nutr Res 2012; 82(3): 148-56.
17. Soare A, Weiss EP, Holloszy JO, et al. Multiple dietary supplements do not affect metabolic and cardio-vascular health. AGING 2014; 6 (2): 149-57.
18. Williamson G, Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studie. Am J Clin Nutr 2005; 81 (1): 243-55.
19. Lacolley P, Challande P, Osborne-Pellegrin M, et al. Genetics and pathophysiology of arterial stiffness. Cardiovascular Research 2009; 81: 637-48.
20. Gritsaenko GA, Belyayev IG. Polymorphism of the genes of renin-angiotensin system and the dysfunction of endothelium in the patients with arterial hypertension and metabolic disorders. Medical herald of Bashkortostan 2013; 8(1): 79-81. Russian (Gritsaenko G. A., Belyaeva I. G. Polimorfizm genov reninangiotenzinovoi sistemy i disfunktsiya endoteliya u bol'nykh arterial'noi gipertoniei s metabolicheskimi narusheniyami. Meditsinskii vestnik Bashkortostana 2013; 8(1): 79-81).
21. Brouilette SW, Whittaker A, Stevens SE. Telomere length is shorter in healthy offspring of subjects with coronary artery disease: support for the telomere hypothesis. Heart 2008; 94: 422-5.
22. De Meyer T, Van Daele CM, De Buyzere ML. No shorter telomeres in subjects with a family history of cardiovascular disease in the Asklepios Study. Arterioscler Thromb Vasc Biol 2012; 32: 3076-81.
23. Ye S, Shaffer JA, Kang MS. Relation between leukocyte telomere length and incident coronary heart disease events (from the 1995 Canadian Nova Scotia Health Survey). Am J Cardiol 2013; 111 (7): 962-7.
24. Lloyd-Jones DM, Hong Y, Labarthe D, et al. American Heart Association Strategic Planning Task Force and Statistics Committee. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation 2010; 121: 586-613.
25. Folsom AR, Yatsuya H, Nettleton JA. et al. ARIC Study Investigators. Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence. JACC 2011; 57: 1690-6.
26. Favero G, Paganelli C, Buffoli B. Endothelium and its alterations in cardiovascular diseases: life style intervention. BioMed Research International 2014. http://dx.doi. org/10.1155 /2014/801896.
27. Houston M. The role of nutrition and nutraceutical supplements in the treatment of hypertension. World J Cardiol 2014; 6 (2): 38-66.
28. Pokrovskaya TG, Kochkarov VI, Pokrovskiy MV, et al. Principles of the pharmacological correction of endothelial dysfunction. Kuban scientific medical herald 2007; 94-95 (1-2): 146-50. Russian (Pokrovskaya T. G., Kochkarov V. I., Pokrovskii M. V. i dr. Printsipy farmakologicheskoi korrektsii endotelial'noi disfunktsii. Kubanskii nauchnyi meditsinskii vestnik 2007; 94-95(1-2): 146-50).
29. Artyushkova EB, Pokrovskiy MV, Artyushkova EV, et al. Metabolic and antioxidant therapy of the L-NAME- induced endothelial disfunction. Kuban scientific medical herald 2008; 3-4: 73-8. Russian (Artyushkova E. B., Pokrovskii M. V., Artyushkova E. V. i dr. Metabolicheskaya i antioksidantnaya terapiya L-NAME- indutsirovannoi endotelial'noi disfunktsii. Kubanskii nauchnyi meditsinskii vestnik 2008; 3-4: 73-8).
30. Romanovskaya GA, Akatova EV, Gorokhovskaya GN, et al. Prospects for the drug treatment of endothelial dysfunction. Pharmateka 2006; 9: 50-56. Russian (Romanovskaya G. A., Akatova E. V., Gorokhovskaya G. N. i dr. Perspektivy medikamentoznogo lecheniya endotelial'noi disfunktsii. Farmateka 2006; 9: 50-56).
31. Boutouyrie P, Achouba A, Trunet P. et al. Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine- atenolol combination: the EXPLOR study. Hypertension 2010; 55: 1314-22.
32. Rasmusen C, Cynober L, Couderc R. Arginin and statins:relationship between the nitric oxide pathway and the atherosclerosis development. Ann Boil Clin 2005; 63 (5): 443-55.
33. Susekov AV, Rozhkova TA, Tripoten MI, et al. The randomized study FARVATER: Part II. Effect of atorvastatin to the function of endothelium, the tensibility and the stiffness of vascular wall. Cardiovascular Therapy and Prevention 2007; 6(3): 68-75. Russian (Susekov A. V., Rozhkova T. A., Tripoten' M. I. i dr. Randomizirovannoe issledovanie FARVATER: Chast' II. Effekt atorvastatina na funktsiyu endoteliya, rastyazhimost' i zhestkost' sosudistoi stenki. Kardiovaskulyarnaya terapiya i profilaktika 2007; 6(3): 68-75).
34. He Y, Si D, Yang C, et al. The effects of amlodipine and S(-)-amlodipine on vascular endothelial function in patients with hypertension. Am J Hypertens 2014; 27(1): 27-31.
35. Kampus P, Serg M, Kals J, et al. Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness. Hypertension 2011; 57(6): 1122-8.
36. Golikov AP, Polumiskov VYu, Mikhin VP, et al. Antioxidants - cytopotectors in cardiology. Cardiovascular Therapy and Prevention 2004; 6 (2): 42-7. Russian (Golikov A. P., Polumiskov V. Yu., Mikhin V. P. i dr. Antioksidanty - tsitoprotektory v kardiologii. Kardiovaskulyarnaya terapiya i profilaktika 2004; 6 (2): 42-7).
37. Kashirina AV. The use of donors of the nitrogen oxide in the treatment of cardiovascular diseases. Successes of the contemporary natural science 2014; 6: 102-3. Russian (Kashirina A. V. Ispol'zovanie donatorov oksida azota v lechenii serdechno-sosudistykh zabolevanii. Uspekhi sovremennogo estestvoznaniya 2014; 6: 102-3).
38. Aroor AR, Demarco VG, Jia G. The role of tissue renin-angiotensin-aldosterone system in the development of endothelial dysfunction and arterial stiffness. Front Endocrinol (Lausanne). 2013; 4: 161.
39. Vasyuk Yu A, Sadulaeva IA, Yushchuk EN, et al. Inhibitors of renin - new direction in the treatment of arterial hypertension. Therapeutic archive 2010; 9: 53-9. Russian (Vasyuk Yu. A., Sadulaeva I. A., Yushchuk E. N. i dr. Ingibitory renina - novoe napravlenie v lechenii arterial'noi gipertonii. Terapevticheskii arkhiv 2010; 9: 53-9).
40. Mukhin NA, Fomin BB. Renin - a target of straight pharmacological blockade in arterial hypertension. Therapeutic archive 2009; 8: 5-9. Russian (Mukhin N. A., Fomin V. V. Renin - mishen' pryamoi farmakologicheskoi blokady pri arterial'noi gipertonii. Terapevticheskii arkhiv 2009; 8: 5-9).
41. Bonadei I, Vizzardi E, D'Aloia A, et al. Role of aliskiren on arterial stiffness and endothelial function in patients with primary hypertension. J Clin Hypertens (Greenwich) 2014; 16(3): 202-6.
42. Andreadis EA, Angelopoulos ET, Kolyvas GN, et al. The effect of aliskiren versus ramipril-based treatment on the Ambulatory Arterial Stiffness Index in hypertensive patients. Int Angiol 2014; 33(1): 78-83.
43. Koumaras C, Tziomalos K, Stavrinou E, et al. Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness. J Am Soc Hypertens 2014; 8 (2): 74-82.
44. Shupenina EYu, Vasyuk YuA, Khadzegova AB, et al. Comparative evaluation of the influence of the basic classes of antihypertensive preparations on the hardness of aorta in the patients with arterial hypertension. Cardiovascular Therapy and Prevention 2014; 13(2): 76-9. Russian (Shupenina E.Yu., Vasyuk Yu. A., Khadzegova A. B. i dr. Sravnitel'naya otsenka vliyaniya osnovnykh klassov antigipertenziv- nykh preparatov na zhestkost' aorty u bol'nykh arterial'noi gipertenziei. Kardiovaskulyarnaya terapiya i profilaktika 2014; 13(2): 76-9).
45. Protogerou AD. Effect of antihypertensive drugs on central blood pressure over and above brachial blood pressure: focusing on blood pressure amplification. Medicographia 2010; 32: 254-61.
46. Zieman S, Melenovsky V, Clattenburg L, et al. Advanced glycation endproducts crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension. J Hypertens 2007; 25 (3): 577-83.
47. Fujimoto N, Hastings JL, Carrick-Ranson G. Cardiovascular effects of 1 year of alagebrium and endurance exercise training in healthy older individuals. Circ Heart Fail 2013; l.6 (6): 1155-64.
48. Namsolleck P, Recarti C, Foulquier S, et al. AT2 Receptor and tissue injury: Therapeutic implications. Curr Hypertens Rep 2014; 16: 416.
49. Vlachopoulus C, Aznaouridis K, Dima I, et al. Negative association between serum levels of matrix metalloproteinases-2 and-9 and aortic stiffness in healthy adults. Int J Cardiol 2007; 122 (3): 232.
50. Cameron JD, Asmar R, Struijker-Boudie H, et al. Current and future initiatives for vascular health management in clinical practice. Vascular Health and Risk Management 2013; 9: 255-64.
Review
For citations:
Kolpakova A.F. DISRUPTIONS OF ELASTIC ARTERIES PROPERTIES AND ENDOTHELIAL FUNCTION: MODERN METHODS FOR CORRECTION AND PREVENTION. Cardiovascular Therapy and Prevention. 2015;14(3):75-81. (In Russ.) https://doi.org/10.15829/1728-8800-2015-3-75-81
Views:
904
ISSN 1728-8800 (Print)
ISSN 2619-0125 (Online)
ISSN 2619-0125 (Online)
Email this article 
